Companies: 10,795·Total market cap: $144.5T
Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc.

LTUSOTCFinancial Services● Active
$0.00
$-0.00(-0.00%)
Market Cap$98773
P/E Ratio—
52W High$0.0111
52W Low$0.0025
Insider TradesOwnershipEmployees

Lotus Pharmaceuticals, Inc. (LTUS) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · LTUS · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Lotus Pharmaceuticals, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

Recent insider transactions

LTUS executive sell shares · LTUS board member insider trading · LTUS insider trading SEC filing

Showing 2 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

WASSERMAN ADAM C

CFO

Other

Date

Aug 21

Shares

50,000

Price

$0.55

Value

$28K

View Form 4 on SEC.gov

WASSERMAN ADAM C

CFO

Other

Date

May 31

Shares

44,200

Price

$1.00

Value

$44K

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About LTUS insider trading

LTUS insider trades

Lotus Pharmaceuticals, Inc. (LTUS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including LTUS. Over the past 12 months, 0 insiders have filed transactions with the SEC. LTUS insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Lotus Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)
OwnershipSEC filingsFinancial statementsPrice historyForecast & ratingsEarnings

Frequently asked questions

LTUS insider trading · 5 questions

The insiders of Lotus Pharmaceuticals, Inc. (LTUS) include executives and directors such as LTUS, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

LTUS board member insider tradingwho are LTUS insidersLTUS insider rosterLotus Pharmaceuticals, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026